Advanced search
1 file | 1.09 MB Add to list

Living related liver transplantation in an adult patient with hepatocellular adenoma and carcinoma 13 years after bone marrow transplantation for Fanconi anemia: a case report

Isabelle Colle (UGent) , Genevieve Laureys (UGent) , Sarah Raevens, Louis Libbrecht (UGent) , Juliaan Leroy (UGent) , KOEN REYNTJENS (UGent) , Anja Geerts (UGent) , Xavier Rogiers (UGent) , Roberto Troisi (UGent) , Holger Hoehn, et al.
(2013) HEPATOLOGY RESEARCH. 43(9). p.991-998
Author
Organization
Abstract
Fanconi anemia (FA) is an inherited bone marrow failure syndrome due to defective DNA inter-strand cross-link repair. Hematopoietic stem cell transplantation (HSCT) is curative for pancytopenia, but may not prevent the development of non-hematological malignancies. We describe a 26-year-old male patient with FA and Marfan syndrome who in 1994 underwent successful HSCT with bone marrow stem cells from his human leukocyte antigen (HLA)-identical sister. In 2006, three lesions in the liver were detected and resected. The three lesions all showed activation of the -catenin pathway and were histologically characterized by a highly differentiated steatotic hepatocellular carcinoma (HCC) with remnants of the underlying adenoma from which it arose, a hepatocellular adenoma with foci of well-differentiatedHCC, and a cholestatic adenoma. Risk factors for the emergence ofHCC includedFA itself, the use of androgens for a period of 3 years precedingHSCT and toxicity of the conditioning regimen. Because of the danger of developing additionalHCC, liver transplantation was proposed, taking into consideration that immunosuppression would increase the risk of other malignancies. By using part of the liver of the sister, who already acted as bone marrow donor 13 years earlier, immunosuppression could be avoided. Liver transplantation was performed in 2007 without complication. Five years after liver transplantation the patient is doing well. This case is twofold special being the first case reportingFA co-occurring withMarfan syndrome and being the first reported case ofFA treated forHCC by liver transplantation from aHLA-identical sibling donor without the use of immunosuppression.
Keywords
PELIOSIS HEPATIS, TUMORS, ANDROGENIC STEROIDS, TOLERANCE INDUCTION, IMMUNOSUPPRESSION WITHDRAWAL, HEPATITIS-B-VIRUS, STEM-CELL INFUSION, ANABOLIC STEROID-THERAPY, SOLID-ORGAN TRANSPLANTATION, hepatocellular carcinoma, Fanconi anemia, bone marrow transplantation, liver transplantation, RECURRENCE

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 1.09 MB

Citation

Please use this url to cite or link to this publication:

MLA
Colle, Isabelle, Genevieve Laureys, Sarah Raevens, et al. “Living Related Liver Transplantation in an Adult Patient with Hepatocellular Adenoma and Carcinoma 13 Years After Bone Marrow Transplantation for Fanconi Anemia: a Case Report.” HEPATOLOGY RESEARCH 43.9 (2013): 991–998. Print.
APA
Colle, Isabelle, Laureys, G., Raevens, S., Libbrecht, L., Leroy, J., REYNTJENS, K., Geerts, A., et al. (2013). Living related liver transplantation in an adult patient with hepatocellular adenoma and carcinoma 13 years after bone marrow transplantation for Fanconi anemia: a case report. HEPATOLOGY RESEARCH, 43(9), 991–998.
Chicago author-date
Colle, Isabelle, Genevieve Laureys, Sarah Raevens, Louis Libbrecht, Juliaan Leroy, KOEN REYNTJENS, Anja Geerts, et al. 2013. “Living Related Liver Transplantation in an Adult Patient with Hepatocellular Adenoma and Carcinoma 13 Years After Bone Marrow Transplantation for Fanconi Anemia: a Case Report.” Hepatology Research 43 (9): 991–998.
Chicago author-date (all authors)
Colle, Isabelle, Genevieve Laureys, Sarah Raevens, Louis Libbrecht, Juliaan Leroy, KOEN REYNTJENS, Anja Geerts, Xavier Rogiers, Roberto Troisi, Holger Hoehn, Detlev Schindler, Helmut Hanenberg, Vincent De Wilde, and Hans Van Vlierberghe. 2013. “Living Related Liver Transplantation in an Adult Patient with Hepatocellular Adenoma and Carcinoma 13 Years After Bone Marrow Transplantation for Fanconi Anemia: a Case Report.” Hepatology Research 43 (9): 991–998.
Vancouver
1.
Colle I, Laureys G, Raevens S, Libbrecht L, Leroy J, REYNTJENS K, et al. Living related liver transplantation in an adult patient with hepatocellular adenoma and carcinoma 13 years after bone marrow transplantation for Fanconi anemia: a case report. HEPATOLOGY RESEARCH. 2013;43(9):991–8.
IEEE
[1]
I. Colle et al., “Living related liver transplantation in an adult patient with hepatocellular adenoma and carcinoma 13 years after bone marrow transplantation for Fanconi anemia: a case report,” HEPATOLOGY RESEARCH, vol. 43, no. 9, pp. 991–998, 2013.
@article{4288156,
  abstract     = {Fanconi anemia (FA) is an inherited bone marrow failure syndrome due to defective DNA inter-strand cross-link repair. Hematopoietic stem cell transplantation (HSCT) is curative for pancytopenia, but may not prevent the development of non-hematological malignancies. We describe a 26-year-old male patient with FA and Marfan syndrome who in 1994 underwent successful HSCT with bone marrow stem cells from his human leukocyte antigen (HLA)-identical sister. In 2006, three lesions in the liver were detected and resected. The three lesions all showed activation of the -catenin pathway and were histologically characterized by a highly differentiated steatotic hepatocellular carcinoma (HCC) with remnants of the underlying adenoma from which it arose, a hepatocellular adenoma with foci of well-differentiatedHCC, and a cholestatic adenoma. Risk factors for the emergence ofHCC includedFA itself, the use of androgens for a period of 3 years precedingHSCT and toxicity of the conditioning regimen. Because of the danger of developing additionalHCC, liver transplantation was proposed, taking into consideration that immunosuppression would increase the risk of other malignancies. By using part of the liver of the sister, who already acted as bone marrow donor 13 years earlier, immunosuppression could be avoided. Liver transplantation was performed in 2007 without complication. Five years after liver transplantation the patient is doing well. This case is twofold special being the first case reportingFA co-occurring withMarfan syndrome and being the first reported case ofFA treated forHCC by liver transplantation from aHLA-identical sibling donor without the use of immunosuppression.},
  author       = {Colle, Isabelle and Laureys, Genevieve and Raevens, Sarah and Libbrecht, Louis and Leroy, Juliaan and REYNTJENS, KOEN and Geerts, Anja and Rogiers, Xavier and Troisi, Roberto and Hoehn, Holger and Schindler, Detlev and Hanenberg, Helmut and De Wilde, Vincent and Van Vlierberghe, Hans},
  issn         = {1386-6346},
  journal      = {HEPATOLOGY RESEARCH},
  keywords     = {PELIOSIS HEPATIS,TUMORS,ANDROGENIC STEROIDS,TOLERANCE INDUCTION,IMMUNOSUPPRESSION WITHDRAWAL,HEPATITIS-B-VIRUS,STEM-CELL INFUSION,ANABOLIC STEROID-THERAPY,SOLID-ORGAN TRANSPLANTATION,hepatocellular carcinoma,Fanconi anemia,bone marrow transplantation,liver transplantation,RECURRENCE},
  language     = {eng},
  number       = {9},
  pages        = {991--998},
  title        = {Living related liver transplantation in an adult patient with hepatocellular adenoma and carcinoma 13 years after bone marrow transplantation for Fanconi anemia: a case report},
  url          = {http://dx.doi.org/10.1111/hepr.12043},
  volume       = {43},
  year         = {2013},
}

Altmetric
View in Altmetric
Web of Science
Times cited: